TrialWorld journal of clinical cases2022

One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or C.

Jing-Hang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.